相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Assessing FDG-PET diagnostic accuracy studies to develop recommendations for clinical use in dementia
Marina Boccardi et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
Clinical utility of FDG-PET for the differential diagnosis among the main forms of dementia
Peter J. Nestor et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
Automated assessment of FDG-PET for differential diagnosis in patients with neurodegenerative disorders
Flavio Nobili et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers
Giovanni B. Frisoni et al.
LANCET NEUROLOGY (2017)
Clinical validity of brain fluorodeoxyglucose positron emission tomography as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework
Valentina Garibotto et al.
NEUROBIOLOGY OF AGING (2017)
Cross-validation of biomarkers for the early differential diagnosis and prognosis of dementia in a clinical setting
Daniela Perani et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
Psychiatric diagnoses underlying the phenocopy syndrome of behavioural variant frontotemporal dementia
F. T. Gossink et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)
Visual Versus Fully Automated Analyses of 18F-FDG and Amyloid PET for Prediction of Dementia Due to Alzheimer Disease in Mild Cognitive Impairment
Timo Grimmer et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
Bruno Dubois et al.
ALZHEIMERS & DEMENTIA (2016)
Mapping brain morphological and functional conversion patterns in predementia late-onset bvFTD
Silvia Morbelli et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
Clinical Impact of a Second FDG-PET in Atypical/Unclear Dementia Syndromes
David Bergeron et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Predicting conversion from MCI to AD with FDG-PET brain images at different prodromal stages
Carlos Cabral et al.
COMPUTERS IN BIOLOGY AND MEDICINE (2015)
Early stage of behavioral variant frontotemporal dementia: clinical and neuroimaging correlates
Barbara Borroni et al.
NEUROBIOLOGY OF AGING (2015)
Volume of interest-based [F-18] fluorodeoxyglucose PET discriminates MCI converting to Alzheimer's disease from healthy controls. A European Alzheimer's Disease Consortium (EADC) study
M. Pagani et al.
NEUROIMAGE-CLINICAL (2015)
Brain metabolic maps in Mild Cognitive Impairment predict heterogeneity of progression to dementia
Chiara Cerami et al.
NEUROIMAGE-CLINICAL (2015)
Visual Versus Semi-Quantitative Analysis of F-18-FDG-PET in Amnestic MCI: An European Alzheimer's Disease Consortium (EADC) Project
Silvia Morbelli et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Prediction of Outcomes in Mild Cognitive Impairment by Using F-18-FDG-PET: A Multicenter Study
Kengo Ito et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
F-18-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)
Nadja Smailagic et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2015)
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
Bruno Dubois et al.
LANCET NEUROLOGY (2014)
Amyloid imaging with 11C-PIB PET/CT and glucose metabolism with 18F-FDG PET/CT in a study on cognitive impairment in the clinical setting
Ignacio Banzo et al.
NUCLEAR MEDICINE COMMUNICATIONS (2014)
A Survey of FDG- and Amyloid-PET Imaging in Dementia and GRADE Analysis
Perani Daniela et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Validation of an optimized SPM procedure for FDG-PET in dementia diagnosis in a clinical setting
Daniela Perani et al.
NEUROIMAGE-CLINICAL (2014)
Guidance for the preparation of neurological management guidelines by EFNS scientific task forces - revised recommendations 2012
M. A. Leone et al.
EUROPEAN JOURNAL OF NEUROLOGY (2013)
Automated analysis of FDG PET as a tool for single-subject probabilistic prediction and detection of Alzheimer's disease dementia
Javier Arbizu et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
Combination of 18F-FDG PET and Cerebrospinal Fluid Biomarkers as a Better Predictor of the Progression to Alzheimer's Disease in Mild Cognitive Impairment Patients
Il Han Choo et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
A follow up study of non-demented patients with primary visual cortical hypometabolism: Prodromal dementia with Lewy bodies
Hiroshige Fujishiro et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2013)
Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease
Annapaola Prestia et al.
NEUROLOGY (2013)
Imaging markers for Alzheimer disease Which vs how
Giovanni B. Frisoni et al.
NEUROLOGY (2013)
Accurate multimodal probabilistic prediction of conversion to Alzheimer's disease in patients with mild cognitive impairment
Jonathan Young et al.
NEUROIMAGE-CLINICAL (2013)
Relation of neuropathology to cognition in persons without cognitive impairment
David A. Bennett et al.
ANNALS OF NEUROLOGY (2012)
Amyloid deposition, hypometabolism, and longitudinal cognitive decline
Susan M. Landau et al.
ANNALS OF NEUROLOGY (2012)
Relationship between baseline brain metabolism measured using [18F]FDG PET and memory and executive function in prodromal and early Alzheimer's disease
Christian Habeck et al.
BRAIN IMAGING AND BEHAVIOR (2012)
Diagnostic accuracy of 18F-FDG and 11C-PIB-PET for prediction of short-term conversion to Alzheimer's disease in subjects with mild cognitive impairment
S. Zhang et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2012)
Glucose hypometabolism in primary visual cortex is commonly associated with clinical features of dementia with Lewy bodies regardless of cognitive conditions
Hiroshige Fujishiro et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2012)
Summary Metrics to Assess Alzheimer Disease Related Hypometabolic Pattern with 18F-FDG PET: Head-to-Head Comparison
Anna Caroli et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Resting metabolic connectivity in prodromal Alzheimer's disease. A European Alzheimer Disease Consortium (EADC) project
Silvia Morbelli et al.
NEUROBIOLOGY OF AGING (2012)
Multi-region analysis of longitudinal FDG-PET for the classification of Alzheimer's disease
Katherine R. Gray et al.
NEUROIMAGE (2012)
Resting state FDG-PET functional connectivity as an early biomarker of Alzheimer's disease using conjoint univariate and independent component analyses
Paule-Joanne Toussaint et al.
NEUROIMAGE (2012)
Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2011)
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Marilyn S. Albert et al.
ALZHEIMERS & DEMENTIA (2011)
Donepezil provides greater benefits in mild compared to moderate Alzheimer's disease: Implications for early diagnosis and treatment
J. L. Molinuevo et al.
ARCHIVES OF GERONTOLOGY AND GERIATRICS (2011)
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia
Katya Rascovsky et al.
BRAIN (2011)
A visual [18F]FDG-PET rating scale for the differential diagnosis of frontotemporal lobar degeneration
Stefan Poljansky et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2011)
Evaluation of a Calibrated 18F-FDG PET Score as a Biomarker for Progression in Alzheimer Disease and Mild Cognitive Impairment
Karl Herholz et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI
Susan M. Landau et al.
NEUROBIOLOGY OF AGING (2011)
Characterizing Alzheimer's disease using a hypometabolic convergence index
Kewei Chen et al.
NEUROIMAGE (2011)
Fluorodeoxyglucose positron emission tomography of mild cognitive impairment with clinical follow-up at 3 years
Jose V. Pardo et al.
ALZHEIMERS & DEMENTIA (2010)
MCI Patients Declining and Not-Declining at Mid-Term Follow-Up: FDG-PET Findings
M. Pagani et al.
CURRENT ALZHEIMER RESEARCH (2010)
Comparison of Neuropsychological and FDG-PET Findings between Early-versus Late-Onset Mild Cognitive Impairment: A Five-Year Longitudinal Study
Sook Hui Kim et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2010)
Mapping brain morphological and functional conversion patterns in amnestic MCI: a voxel-based MRI and FDG-PET study
Silvia Morbelli et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
Unawareness of Memory Deficit in Amnestic MCI: FDG-PET Findings
Flavio Nobili et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Revising the definition of Alzheimer's disease: a new lexicon
Bruno Dubois et al.
LANCET NEUROLOGY (2010)
Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging
Christopher C. Rowe et al.
NEUROBIOLOGY OF AGING (2010)
Comparing predictors of conversion and decline in mild cognitive impairment
S. M. Landau et al.
NEUROLOGY (2010)
Diffuse occipital hypometabolism on [18F]-FDG PET scans in patients with idiopathic REM sleep behavior disorder: Prodromal dementia with Lewy bodies?
Hiroshige Fujishiro et al.
PSYCHOGERIATRICS (2010)
Fluorodeoxyglucose-Positron-Emission Tomography, Single-Photon Emission Tomography, and Structural MR Imaging for Prediction of Rapid Conversion to Alzheimer Disease in Patients with Mild Cognitive Impairment: A Meta-Analysis
Y. Yuan et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2009)
Combined magnetic resonance imaging and positron emission tomography brain imaging in behavioural variant frontotemporal degeneration: refining the clinical phenotype
C. M. Kipps et al.
BRAIN (2009)
Clinical Trajectories and Biological Features of Primary Progressive Aphasia (PPA)
E. J. Rogalski et al.
CURRENT ALZHEIMER RESEARCH (2009)
FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer's disease
Lisa Mosconi et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2009)
Comparison of 18F-FDG and PiB PET in Cognitive Impairment
Val J. Lowe et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI)
Jessica B. S. Langbaum et al.
NEUROIMAGE (2009)
Principal component analysis of FDG PET in amnestic MCI
Flavio Nobili et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2008)
Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias
Lisa Mosconi et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Education and occupation as proxies for reserve in aMCI converters and AD FDG-PET evidence
V. Garibotto et al.
NEUROLOGY (2008)
18F-FDG PET database of longitudinally confirmed healthy elderly individuals improves detection of mild cognitive impairment and Alzheimer's disease
Lisa Mosconi et al.
JOURNAL OF NUCLEAR MEDICINE (2007)
Diagnostic value of FDG-PET and HMPAO-SPET in patients with mild dementia and mild cognitive impairment: Metabolic index and perfusion index
N Dobert et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2005)
MCI conversion to dementia and the APOE genotype -: A prediction study with FDG-PET
L Mosconi et al.
NEUROLOGY (2004)
Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study
A Drzezga et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2003)
Mild cognitive impairment -: Can FDG-PET predict who is to rapidly convert to Alzheimer's disease?
G Chételat et al.
NEUROLOGY (2003)
分享论文
